Alcoholic liver disease: A synopsis of the Charles Lieber's memorial symposia 2009-2012

Alcohol and Alcoholism

Volumn 49, Issue 4, 2014, Pages 373-380

  Neuman, Manuela G ^a,b   Cohen, Lawrence ^c   Zakhari, Samir ^d   Nanau, Radu M ^a,b   Mueller, Sebastian ^e   Schneider, Michelle ^f   Parry, Charles ^f   Isip, Romina ^a,b   Seitz, Helmut K ^e  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CYTOCHROME P450 2E1; HISTAMINE H2 RECEPTOR ANTAGONIST; CYTOCHROME P450 2E1 INDUCER;

ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ALCOHOL BLOOD LEVEL; ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; ARTICLE; CHRONIC HEPATITIS; COMORBIDITY; DISEASE ASSOCIATION; DRUG INTERACTION; END STAGE LIVER DISEASE; FIBROGENESIS; FIRST PASS EFFECT; GENETIC POLYMORPHISM; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LIVER CARCINOGENESIS; LIVER MICROSOME; LIVER TRANSPLANTATION; MEDICAL LITERATURE; MEDICAL SOCIETY; PATIENT COUNSELING; PRIORITY JOURNAL; PROTEIN FUNCTION; QUALITY OF LIFE; SURVIVAL RATE; SYMPOSIUM; VIRUS HEPATITIS; ADVERSE EFFECTS; COMPLICATION; ENZYMOLOGY; GENETICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; METABOLISM; MORTALITY;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CYTOCHROME P-450 CYP2E1 INDUCERS; DRUG INTERACTIONS; ETHANOL; HEPATITIS C, CHRONIC; HISTAMINE H2 ANTAGONISTS; HIV INFECTIONS; HUMANS; LIVER DISEASES, ALCOHOLIC; LIVER TRANSPLANTATION;

EID: 84902479471     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agu021     Document Type: Article

References (99)

1. Ambade A, Mandrekar P. (2012) Oxidative stress and inflammation: essential partners in alcoholic liver disease. Int J Hepatol 2012:853175.
2. Amir I, Anwar N, Baraona E et al. (1996) Ranitidine increases the bioavailability of imbibed alcohol by accelerating gastric emptying. Life Sci 58:511-8.
3. Bansal S, Liu CP, Sepuri NB et al. (2010) Mitochondria-targeted cytochrome P450 2E1 induces oxidative damage and augments alcohol-mediated oxidative stress. J Biol Chem 285:24609-19.
4. Bautista AP. (2001) Free radicals, chemokines, and cell injury in HIV-1 and SIV infections and alcoholic hepatitis. Free Radic Biol Med 31:1527-32.
5. Benhamou Y, Bochet M, Di Martino V et al. (1999) Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 30:1054-8.
6. Biava C. (1964) Mallory alcoholic hyalin. A hereto-fore unique lesion of hepatocellular ergastoplasm. Lab Invest 13:1301.
7. Birley AJ, James MR, Dickson PA et al. (2009) ADH single nucleotide polymorphism associations with alcohol metabolism in vivo. Hum Mol Genet 18:1533-42.
8. Bode C, Bode JC. (2005) Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol? Alcohol Clin Exp Res 29:166S.
9. Bode C, Kugler V, Bode JC. (1987) Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol 4:8.
10. Braithwaite RS, McGinnis KA, Conigliaro J et al. (2005) A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcohol Clin Exp Res 29:1190-7.
11. Caballería J, Baraona E, Deulofeu R et al. (1991) Effects of H2-receptor antagonists on gastric alcohol dehydrogenase activity. Dig Dis Sci 36:1673-9.
12. Cameron RG, Neuman MG. (1999) Novel morphologic findings in alcoholic liver disease. Clin Biochem 32:579-84.
13. Castellares C, Barreiro P, Martín-Carbonero L et al. (2008) Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome. J Viral Hepat 15:165-72.
14. Chavez PRG, Lian F, Chung J et al. (2011) Long term ethanol consumption promotes hepatic tumorigenesis but impairs normal hepatocyte proliferation in rats. J Nutr 141:1049-55.
15. Chiang CP, Wu CW, Lee SP et al. (2012) Expression pattern, ethanol-metabolizing activities, and cellular localization of alcohol and aldehyde dehydrogenases in human small intestine. Alcohol Clin Exp Res 36:2047-58.
16. Cohen C, Benjamin M. (1991) Alcoholics and liver transplantation. The Ethics and Social Impact Committee of the Transplant and Health Policy Center. JAMA 265:1299-301.
17. Degré D, Lemmers A, Gustot T et al. (2012) Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates. Clin Exp Immunol 169:302-10.
18. Denk H, Franke WW, Dragosics B et al. (1981) Pathology of cytoskeleton of liver cells: demonstration of Mallory bodies (alcoholic hyalin) in murine and human hepatocytes by immunofluorescence microscopy using antibodies to cytokeratin polypeptides from hepatocytes. Hepatology 1:9-11.
19. Devito C, Hejdeman B, Albert J et al. (2006) Antiretroviral therapy does not induce HIV type 1-specific neutralizing activity against autologous HIV type 1 isolates. AIDS Res Hum Retroviruses 22:908-11.
20. DiPadova C, Roine R, Frezza M et al. (1992) Effects of ranitidine on blood alcohol levels after ethanol ingestion. Comparison with other H2-receptor antagonists. JAMA 267:83-6.
21. Ellard GA. (1984) The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis. Tubercle 65:211-4.
22. Feinman L, Lieber CS. (1999) Ethanol and lipid metabolism. Am J Clin Nutr 70:791-2.
23. French SW. (1981) The Mallory body: structure, composition and pathogenesis. Hepatology 1:76-81.
24. French BA, Oliva J, Bardag-Gorce F et al. (2011) The immunoproteasome in steatohepatitis: its role in Mallory-Denk body formation. Exp Mol Pathol 90:252-6.
25. Gäbele E, Brenner DA, Rippe RA. (2003) Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Front Biosci 8:d69-77.
26. Grove J, Brown AS, Daly AK et al. (1998) The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype. Pharmacogenetics 8:335-42.
27. Haber PS, Gentry RT, Mak KM et al. (1996) Metabolism of alcohol by human gastric cells: relation to first-pass metabolism. Gastroenterology 111:863-70.
28. Hirbod T, Nilsson J, Andersson S et al. (2006) Upregulation of interferon-alpha and RANTES in the cervix of HIV-1-seronegative women with high-risk behavior. J Acquir Immune Defic Syndr 43:137-43.
29. Horvath E, Kovacs K, Ross RC. (1973) Alkoholische Leberschadigung. Haufigkeit und diagnostischer Wert der Feinstructurellen Veranderungen in den Leberzellen. Beitr Path Bd 148:67.
30. Huang YS, Chern HD, Su WJ et al. (2003) Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. Hepatology 37:924-30.
31. Josan S, Xu T, Yen YF et al. (2013) In vivo measurement of aldehyde dehydrogenase-2 activity in rat liver ethanol model using dynamic MRSI of hyperpolarized [1-(13) C]pyruvate. NMR Biomed 26:607-12.
32. Kalichman SC, Amaral CM, White D et al. (2012) Alcohol and adherence to antiretroviral medications: interactive toxicity beliefs among people living with HIV. J Assoc Nurses AIDS Care 23:511-20.
33. Klassen LW, Tuma D, Sorrell M. (1995) Immune mechanisms of alcohol-induced liver disease. Hepatology 22:355-8.
34. Krawczyk M, Grat M, Barski K et al. (2012) 1000 liver transplantations at the Department of general, transplant and liver surgery, Medical University of Warsaw-analysis of indications and results. Pol Przegl Chir 84:304-12.
35. Lai CL, Li YP, Liu CM et al. (2013) Inhibition of human alcohol and aldehyde dehydrogenases by cimetidine and assessment of its effects on ethanol metabolism. Chem Biol Interact 202:275-82.
36. Leandro G, Mangia A, Hui J et al. (2006) Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology 130:1636-42.
37. Lee HC, Lee HS, Jung SH et al. (2001) Association between polymorphisms of ethanol-metabolizing enzymes and susceptibility to alcoholic cirrhosis in a Korean male population. J Korean Med Sci 16:745-50.
38. Lefkowitch JH. (2005) Morphology of alcoholic liver disease. Clin Liver Dis 9:37-53.
39. Li D, Zhao H, Gelernter J. (2012) Strong protective effect of the aldehyde dehydrogenase gene (ALDH2) 504lys (*2) allele against alcoholism and alcohol-induced medical diseases in Asians. Hum Genet 131:725-37.
40. Lieber CS. (2004) CYP2E1: from ASH to NASH. Hepatol Res 28:1-11.
41. Lieber CS, DeCarli LM. (1968) Ethanol oxidation by hepatic microsomes: adaptive increase after ethanol feeding. Science 162:917.
42. Lieber CS, DeCarli LM. (1970) Hepatic microsomal ethanol oxidizing system. In vitro characteristics and adaptive properties in vivo. J Biol Chem 245:2505-12.
43. Lieber CS, Robins SJ, Leo MA. (1994) Hepatic phosphatidylethanolamine methyltransferase activity is decreased by ethanol and increased by phosphatidylcholine. Alcohol Clin Exp Res 18:592-5.
44. Lindquist JN, Stefanovic B, Brenner DA. (2000) Regulation of collagen alpha1(I) expression in hepatic stellate cells. J Gastroenterol 35 Suppl 12:80-3.
45. Liu C, Chung J, Seitz HK et al. (2002) Chlormethiazole treatment prevents reduced hepatic vitamin A levels in ethanol-fed rats. Alcoholism Clin Exp Res 26:1703-9.
46. Lönnroth K, Williams BG, Stadlin S et al. (2008) Alcohol use as a risk factor for tuberculosis-a systematic review. BMC Public Health 8:289.
47. Lucey MR. (2002) Is liver transplantation an appropriate treatment for acute alcoholic hepatitis? J Hepatol 36:829-31.
48. Machado MV, Martins A, Almeida R et al. (2009) Does the simultaneous tumor necrosis factor receptor 2, tumor necrosis factor promoter gene polymorphism represent a higher risk for alcoholic liver disease? Eur J Gastroenterol Hepatol 21:201-5. doi:10.1097/MEG.0b013e32831016e0.
49. Macías J, Berenguer J, Japón MA et al. (2012) Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients. Hepatology 56:1261-70.
50. Mallory FB. (1911) Cirrhosis of the liver. Five different types of lesions from which it may arise. Bull Johns Hopkins Hosp 22:69.
51. Mao Q, Gao L, Wang H et al. (2012) The alcohol dehydrogenase 1C(rs698) Genotype and breast cancer: a meta-analysis. Asia Pac J Public Health [Epub ahead of print]. doi: 10.1177/1010539512446962.
52. Marra F, DeFranco R, Grappone C et al. (1998) Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am J Pathol 152: 423-30.
53. Mathurin P, Moreno C, Samuel D et al. (2011) Early liver transplantation for severe alcoholic hepatitis. N Engl J Med 365:1790-800.
54. Mathurin P, Hadengue A, Bataller R et al. (2012) European Association for the Study of Liver clinical practical guidelines: management of alcoholic liver disease. J Hepatol 57:399-420. doi: 10.1016/j.jhep.2012.04.004.
55. McCallum S, Masterton G. (2006) Liver transplantation for alcoholic liver disease: a systematic review of psychosocial selection criteria. Alcohol Alcohol 41:358-63.
56. McCullough AJ, Falck-Ytter Y. (1999) Body composition and hepatic steatosis as precursors for fibrotic liver disease. Hepatology 29:1328-30.
57. Millonig G, Bernhardt F, Wang Y et al. (2011) Ethanol-mediated carcinogenesis in the human esophagus implicates cytochrome P-4502E1 induction and the generation of carcinogenic DNA-lesions. Int J Cancer 128:533-40.
58. Moriya M, Zhang W, Johnson F et al. (1994) Mutagenic potency of exocyclic DNA adducts: marked differences between Escherichia coli and simian kidney cells. Proc Natl Acad Sci USA 91:11899-903.
59. Murphy FR, Issa R, Zhou X et al. (2002) Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem 277:11069-76.
60. Nair J, Srivatanakul P, Haas C et al. (2010) High urinary excretion of lipid peroxidation-derived DNA damage in patients with cancer prone liver diseases. Mutation Res 683:23-8.
61. Neuman MG. (1999) Cytokines and inflamed liver. Clin Biochem 33:601-5.
62. Neuman MG. (2003) Cytokines-central factors in alcoholic liver disease. Alcohol Res Health 27:307-16.
63. Neuman MG, Koren G, Tiribelli C. (1993) In vitro assessment of the ethanol-induced hepatotoxicity on HepG2 cell line. Biochem Biophys Res Commun 197:932-41.
64. Neuman MG, Shear NH, Bellentani S et al. (1998) Role of cytokines in ethanol-induced hepatocytotoxicity in Hep G2 cells. Gastroenterology 114:157-69.
65. Neuman MG, Cameron RG, Haber J et al. (1999a) Inducers of cytochrome P450 2E1 enhance methotrexate-induced hepatocytotoxicity. Clin Biochem 32:519-36.
66. Neuman MG, Shear NH, Cameron RG et al. (1999b) Ethanol-induced apoptosis in vitro. Clin Biochem 32:547-55.
67. Neuman MG, Brenner DA, Rehermann B et al. (2001) Mechanisms of alcoholic liver disease: cytokines. Alcohol Clin Exp Res 25:251S-3S.
68. Neuman MG, Benhamou JP, Bourliere M et al. (2002a) Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy. Cytokine 17:108-17.
69. Neuman MG, Benhamou JP, Malkiewicz IM et al. (2002b) Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis. J Viral Hepat 9:134-40.
70. Neuman MG, Monteiro M, Rehm J. (2006) Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses. Subst Use Misuse 41:1395-463.
71. Neuman MG, Sha K, Esguerra R et al. (2008) Inflammation and repair in viral hepatitis C. Dig Dis Sci 53:1468-87.
72. Neuman MG, Schmilowitz-Weiss H, Hilzenrat N et al. (2012a) Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis C. Int J Hepatol 2012:231210.
73. Neuman MG, Schneider M, Nanau RM et al. (2012b) Alcohol consumption, progression of disease and other comorbidities, and responses to antiretroviral medication in people living with HIV. AIDS Res Treat 2012:751827.
74. Nguyen-Khac E, Houchi H, Daoust M et al. (2010) Lack of association between tumour necrosis factor receptor types 1 and 2 gene polymorphism and severe acute alcoholic hepatitis. Eur J Gastroenterol Hepatol 22:794-800.
75. Norton ID, Apte MV, Haber PS et al. (1998) Cytochrome P4502E1 is present in rat pancreas and is induced by chronic ethanol administration. Gut 42:426-30.
76. Okamoto K, Murawaki Y, Yuasa AI et al. (2001) Effect of ALDH2 and CYP2E1 gene polymorphisms on drinking behavior and alcoholic liver disease in Japanese male workers. Alcohol Clin Exp Res 25:19S-23S.
77. Oneta CM, Lieber CS, Li JJ et al. (2002) Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase. J Hepatol 36:47-52.
78. O'Shea RS, Dasarathy S, McCullough AJ, and the Practice Guideline Committee of the American Association for the Study of Liver Diseases and the Practice Parameters Committee of the American College of Gastroenterology. (2010) AASLD Practice Guideline Alcoholic Liver Disease. Hepatology 51:307-28.
79. Porta EA, Bergman BJ, Stein AA. (1965) Acute alcoholic hepatitis. Am J Pathol 46:657.
80. Raufman JP, Notar-Francesco V, Raffaniello RD et al. (1993) Histamine-2 receptor antagonists do not alter serum ethanol levels in fed, nonalcoholic men. Ann Intern Med 118:488-94.
81. Samet JH, Horton NJ, Traphagen ET et al. (2003) Alcohol consumption and HIV disease progression: are they related? Alcohol Clin Exp Res 27:862-7.
82. Seitz HK, Stickel F. (2007) Molecular mechanisms of alcoholmediated carcinogenesis. Nat Rev Cancer 7:599-612.
83. Seitz HK, Korsten MA, Lieber CS. (1979) Ethanol oxidation by intestinal microsomes: increased activity after chronic ethanol administration. Life Sci 25:1443-8.
84. Seitz HK, Boesche J, Czygan P et al. (1982) Microsomal ethanol oxidation in the colonic mucosa of the rat. Effect of chronic ethanol ingestion. Naunyn Schmiedebergs Arch Pharmacol 320:81-4.
85. Sheron N, Bird G, Koskinas J et al. (1993) Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 18:41-6.
86. Singal AK, Bashar H, Anand BS et al. (2012) Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database. Hepatology 55:1398-405.
87. Stickel F, Oesterreicher CH. (2006) The role of genetic polymorphisms in alcoholic liver disease. Alcohol Alcohol 41:209-24.
88. Tsutsumi M, Ishizaki M, Takada A. (1996) Relative risk for the development of hepatocellular carcinoma in alcoholic patients with cirrhosis: a multiple logistic-regression coefficient analysis. Alcohol Clin Exp Res 20:758-62.
89. Varma V, Webb K, Mirza DF. (2010) Liver transplantation for alcoholic liver disease. World J Gastroenterol 16:4377-93.
90. Vidal F, Lorenzo A, Auguet T et al. (2004) Genetic polymorphisms of ADH2, ADH3, CYP4502E1 Dra-I and Pst-I, and ALDH2 in Spanish men: lack of association with alcoholism and alcoholic liver disease. J Hepatol 41:744-50.
91. Weinberg DS, Burnham D, Berlin JA. (1998) Effect of histamine-2 receptor antagonists on blood alcohol levels: a meta-analysis. J Gen Intern Med 13:594-9.
92. Whitcomb DC, Block GD. (1994) Association of acetaminophen toxicity with fasting and ethanol use. JAMA 272:1845-9.
93. Wilsnack RW, Wilsnack SC, Kristjanson AF et al. (2009) Gender and alcohol consumption: patterns from the multinational GENACIS project. Addiction 104:1487-500.
94. Worner TM, Lieber CS. (1985) Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 254:627-30.
95. Yokoo H, Minick OT, Batti F et al. (1972) Morphologic variants of alcoholic hyalin. Am J Pathol 69:25.
96. Zimmerman HJ. (1968) The spectrum of hepatotoxicity. Prospect Biol Med 12:135-61.
97. Zimmerman HJ. (1981) Effects of aspirin and acetaminophen on the liver. Arch Intern Med 141:333-8.
98. Zintzaras E, Stefanidis I, Santos M et al. (2006) Do alcoholmetabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease? Hepatology 43:352-61.
99. Zuo L, Zhang H, Malison RT et al. (2013) Rare ADH Variant Constellations are Specific for Alcohol Dependence. Alcohol Alcohol 48:9-14.